Related references
Note: Only part of the references are listed.Back to the Future: Mismatched Unrelated Donor, Haploidentical Related Donor, or Unrelated Umbilical Cord Blood Transplantation?
Claudio Anasetti et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
Saar Gill et al.
BLOOD (2012)
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Natalia Lapteva et al.
CYTOTHERAPY (2012)
Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
Tarun K. Garg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The role of natural killer cells in immunity against multiple myeloma
James Godfrey et al.
LEUKEMIA & LYMPHOMA (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
Role of Killer Immunoglobulin-like Receptor-Ligand Interactions in Human Leukocyte Antigen-Matched Sibling Hematopoietic Stem Cell Transplantation
U. Kanga et al.
TRANSPLANTATION PROCEEDINGS (2012)
Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells
Eirini Katodritou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma
Luisa Giaccone et al.
BLOOD (2011)
Milestones in umbilical cord blood transplantation
Eliane Gluckman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up
Bo Bjorkstrand et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial
Amrita Krishnan et al.
LANCET ONCOLOGY (2011)
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
N. Kroeger et al.
LEUKEMIA (2011)
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
Jan Spanholtz et al.
PLOS ONE (2011)
Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
Roel Willemze et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That Is Reversed With IL-2 Exvivo Expansion
Dongxia Xing et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
V. Hoyos et al.
LEUKEMIA (2010)
High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
Jan Spanholtz et al.
PLOS ONE (2010)
The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor Cells
Rose C. Beck et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity
Claudio G. Brunstein et al.
BLOOD (2009)
Human-Like Mouse Models for Testing the Efficacy and Safety of Anti-β2-Microglobulin Monoclonal Antibodies to Treat Myeloma
Jing Yang et al.
CLINICAL CANCER RESEARCH (2009)
Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma
Jean-Luc Harousseau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
Laura Rosinol et al.
BLOOD (2008)
Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
Evren Alici et al.
BLOOD (2008)
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
Jumei Shi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Formation and function of the lytic NK-cell immunological synapse
Jordan S. Orange
NATURE REVIEWS IMMUNOLOGY (2008)
Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model
Evren Alici et al.
EXPERIMENTAL HEMATOLOGY (2007)
Epstein!Barr virus-specific cytotoxic T lymphocytes expressing the anti-CD30ξ artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease
Barbara Savoldo et al.
BLOOD (2007)
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
Jeffery S. Miller et al.
BLOOD (2007)
Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors
Andreas Lundqvist et al.
BLOOD (2007)
Clinical stage-depending decrease of NK cell activity in multiple myeloma patients
Vladimir Jurisic et al.
MEDICAL ONCOLOGY (2007)
KIR Ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy
Katharine C. Hsu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function
Pedro Roda-Navarro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma
C Fauriat et al.
LEUKEMIA (2006)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Use of natural killer cells in hematopoetic stem cell transplantation
JR Passweg et al.
BONE MARROW TRANSPLANTATION (2005)
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells
E Carbone et al.
BLOOD (2005)
T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells
MJ Townsend et al.
IMMUNITY (2004)
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia
MJ Laughlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia
V Rocha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation
L Ruggeri et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
The immunological synapse of CTL contains a secretory domain and membrane bridges
JC Stinchcombe et al.
IMMUNITY (2001)
Share Paper
